The hypocholesterolemic effect of Stachytarpheta cayennensis tea: Implications for the management of obesity and hypertension

Asian Journal of Biochemistry

Volumn 3, Issue 4, 2008, Pages 267-270

  Chigozie, Ikewuchi Jude ^a   Eloghosa, Osaghae Blessing ^a   Augusta, Osagie ^b  

^a BENSON IDAHOSA UNIVERSITY   (Nigeria)

^b AMBROSE ALLI UNIVERSITY   (Nigeria)

Author keywords

Hypertension; Hypocholesterolemia; Obesity; Plasma total cholesterol; Stachytarpheta cayennensis

Indexed keywords

ORYCTOLAGUS CUNICULUS; STACHYTARPHETA CAYENNENSIS;

EID: 44449150328     PISSN: 18159923     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajb.2008.267.270     Document Type: Article

References (29)

1. ADA (American Dietetic Association), 2005. Disorders of lipid metabolism evidence-based nutrition practice guideline. Chicago (IL): Am. Diet. Assoc., pp: 17.
2. Adebajo, A.C., E.O. Olawode, O.R. Omobuwajo, S.A. Adesanya, F. Begrow, A. Elkhawad, M.A. Akanmu, R. Edrada, P. Proksch T.J. Schmidt, M. Klaes and E.J. Verspohl, 2007. Hypoglycemic constituent of Stachytarpheta cayennensis leaf. Planta Med., 73 (3): 241-250.
3. Adjanahoun, E., M.R.A. Ahyi, L. Ake-Assi, J.A. Elewude, K. Dramane, S.O. Fadoju, Z.O. Gbile, E. Goudole, O.L.A. Johnson, A. Keita, O. Morakinyo, J.A.O. Ojewole, A.O. Olatunji and E.A. Sofowora, 1991. Traditional medicine and pharmacopoeia. Contribution to ethnobotanical floristic studies in Western Nigeria. Publication Organization of African Unity, Scientific Technical and Research Commission Lagos, Nigeria, pp: 420.
4. Akanmu, M.A., G. Olayiwola, O.E. Ukponmwan and K. Honda, 2005. Acute toxicity and sleep-wake EEG analysis of Stachytarpheta cayennensis (Verbenaceae) in Rodents. Afr. J. Trad. CAM., 2 (3): 222-232.
5. Ames, R.P., 1991. Hyperlipidemia in hypertension: Causes and prevention. Am. Heart J., 122 (4pt2): 1219-1224.
6. Ames, R., 1998. Hyperlipidemia of diuretic therapy. Arch. Mal. Coeur. Vaiss., 91 (suppl): 23-27.
7. Batchelder, H.J., 1995. Pharmacognosy. Herbal Research Publications. www.biologie.uni-hamburg.de/b-online/ibc99/poison/pharmacognosyl.html. (Accessed July 2007).
8. Becque, M.D., V.L. Katch, A.P. Rocchini, C.R. Marks and C. Moorehead, 1988. Coronary risk incidence of obese adolescents: Reduction by exercise plus diet intervention. Pediatrics, 81: 605-612.
9. Dwyer, J.T., B.R. Goldin, N. Saul, L. Gaultieri, S. Bakarat and H. Adiercruetz, 1994. Tofu and Soy drinks contain phytoestrogens. J. Am. Diet. Assoc., 94: 739-743.
10. Ferreira, L.H., S.H. Bernardes, J.A. Soares, B. Filho, F.M. Consolim-Colombo, G.D.M. Artigas and K.E. Moacyr, 1997. Lipid metabolism alterations in normotensive subjects with positive history of hypertension. Hypertension, 30 (2): 627-631.
11. Freis, E.D., D.J. Reda and B.J. Materson, 1988. Volume (weight) loss and blood pressure following thiazide diuretics. Hypertension, 12: 244-250.
12. Howard, B.V. and D. Kritchevsky, 1997. Phytochemicals and cardiovascular disease: A statement for healthcare professionals from the american heart association. Circulation, 95: 2591-2593.
13. Igoli, J.O., O.G. Ogaji, T.A. Tor-Anyiin and N.P. Igoli, 2005. Traditional medicine practice amongst the igede people of Nigeria. Part II. Afr. J. Trad. CAM., 2 (2): 134-152.
14. Kwiterovich, P.O. Jr., 1995. Detection and Treatment of Elevated Blood Lipids and Other Risk Factors for Coronary Artery Disease in Youth. In: Recent Advances in Atherosclerosis Research, Numano, F. and R.W. Wissler (Eds.). The 3rd Saratoga International Conference on Atherosclerosis in Nekoma. NYAS, 748: 313-332.
15. Kwiterovich, P.O. Jr., 1998. The antiatherogenic role of high density lipoprotein cholesterol. Am. J. Cardiol., 82: Q13-21.
16. Martirosyan, D.M., L.A. Miroshnichenko, S.N. Kulokawa, AN. Pogojeva and V.I. Zoloedov, 2007. Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis., 6: 1.
17. Mattson, F.H., S.M. Grandy and J.R. Crouse, 1982. Optimizing the effect of plant sterols on cholesterol absorption in man. Am. J. Clin. Nutr., 35: 697-700.
18. Melita Rodriguez, S. and O. Castro, 1996. Pharmacological and chemical evaluation of Stachytarpheta cayennensis (Verbenaceae). Rev. Biol. Trop., 44 (2A): 353-357.
19. Mesia-Vela, S., C. Souccar, M.T. Lima-Lindman and A.J. Lapa, 2004. Pharmacological study of Stachytarpheta cayennensis Vahl in rodents. Phytomedicine, 11 (7-8): 616-624.
20. Middleton, E. Jr., C. Kandaswami and T.C. Theoharides, 2000. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev., 52: 673-751.
21. Ostlund, R.E. Jr. and X. Lin, 2006. Regulation of cholesterol absorption by phytosterols. Curr. Atheroscler. Rep., 8: 487-491.
22. Penido, C., K.A. Costa, D.O. Futuro, S.K. Paiva, M.A. Kaplan, M.R. Figueiredo and M.G. Henriques, 2006. Anti-inflammatory and antiulcerogenic properties of Stachytarpheta cayennensis (L.C. Rich) Vahl. J. Ethnopharmacol., 104 (1-2): 225-233.
23. Raintree Nutrition, 2007. Presence of compounds in Gervao (Stachytarpheta cayennensis). www.rain-tree.com/ gervao-chemicals.pdf (Accessed July 2007).
24. Reisin, E., R. Able and M. Modan, 1978. Effect of weight loss without salt restriction in the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med., 298: 1-6.
25. Rukmini, C. and T.C. Raghuram, 1991. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review. J. Am. Coll. Nutr., 10: 593-601.
26. Schapoval, E.E.S., M.R. Winter de Varga, C.G. Chaves, R. Bridi, J.A. Zuanazzi and A.T. Henriques, 1998. Anti-inflammatory and antinociceptive activities of the extract and isolated compounds for Stachytarpheta cayennensis. J. Ethnopharmacol., 60: 53-59.
27. Taylor, L., 2005. The Healing Power of Rainforest Herbs. Gervao. www.rain.tree.com/gervao.html (Accessed June 2007).
28. Tilvis, R. S. and T.A. Miettinen, 1986. Serum plant sterols and their relation to cholesterol absorption. Am. J. Clin. Nutr., 43: 92-97.
29. Zicha, J., J. Kunes and M.A. Devynck, 1999. Abnormalities of membrane function and lipid metabolism in hypertension: A review. Am. J. Hypertens., 12 (3): 315-331.